Compare · ALUR vs MDLN
ALUR vs MDLN
Side-by-side comparison of Allurion Technologies Inc. (ALUR) and Medline Inc. (MDLN): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both ALUR and MDLN operate in Medical/Dental Instruments (Health Care), so they compete in similar markets.
- MDLN carries a market cap of $48.08B.
- MDLN has been more active in the news (7 items in the past 4 weeks vs 1 for ALUR).
- MDLN has more recent analyst coverage (25 ratings vs 4 for ALUR).
- Company
- Allurion Technologies Inc.
- Medline Inc.
- Price
- -
- -
- Market cap
- -
- $48.08B
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Medical/Dental Instruments
- Medical/Dental Instruments
- Exchange
- NYSE
- NASDAQ
- IPO
- 2025
- News (4w)
- 1
- 7
- Recent ratings
- 4
- 25
Latest ALUR
- SEC Form 25-NSE filed by Allurion Technologies Inc.
- Amendment: SEC Form SCHEDULE 13D/A filed by Allurion Technologies Inc.
- Allurion Technologies Inc. filed SEC Form 8-K: Leadership Update
- SEC Form NT 10-Q filed by Allurion Technologies Inc.
- Allurion Technologies Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits
- Amendment: SEC Form SCHEDULE 13D/A filed by Allurion Technologies Inc.
- Large owner Rtw Investments, Lp disposed of 392,766 shares (SEC Form 4)
- Allurion Technologies Inc. filed SEC Form 8-K: Leadership Update
- Allurion Technologies Inc. filed SEC Form 8-K: Leadership Update
- Allurion Technologies Inc. filed SEC Form 8-K: Leadership Update
Latest MDLN
- SEC Form 8-K filed by Medline Inc.
- Medline to build Midwestern network with new 800,000-square-foot facility in Van Buren Township, Mich.
- SEC Form 4 filed by Medline Inc.
- Medline launches enhanced TrackPoint™ to simplify inventory management for post-acute care
- SEC Form 4 filed by Medline Inc.
- MEDLINE INC. MDLN INVESTORS: Contact Kirby McInerney LLP About the Firm’s Securities Investigation Following 12.8% Share Drop
- Medline to report third quarter 2026 results on November 4, 2026
- INVESTOR ACTION NOTICE: Moore Law PLLC Encourages Investors in Medline Inc. to Contact Law Firm
- Medline announces participation in the Morgan Stanley 24th Annual Global Healthcare Conference
- SEC Form 4 filed by Chief Executive Officer Boyle James M